REGISTRATION FOR AWACC 2019 IS NOW OPEN.
29 - 30 AUGUST 2019
ELANGENI HOTEL DURBAN
This annual workshop which started in 2007 has been held yearly .
The first workshop was a joint effort of the Centre for AIDS research (CFAR) of Harvard Medical school and McCord Hospital (MH) ,Durban South Africa.
Please note that CPD points including ethics
points will be allocated for the conference.
The conference secretariat for AWACC 2016 will be managed by the NPC - MEDICATE-AIDS.
The directors are committed to continue to engage with our partners to ensure the success of this premier CME activity in the clinical care of people living with HIV.
Register for AWACC 2019
29 & 30 August 2019 at Elangeni Hotel
Organisations wanting to register more than 1 delegate may download and complete the organisation registration form here.
Individuals wanting to register manually may download and complete the manual registration form here.
Online registration may be requested by filling all mandatory fields and submitting, for which, you will receive an automatic reply.
The registration fee TBA
Payment may be made into the following account.
Bank: Standard Bank
Name of the Business Account: Medicate-Aids
Account Number : 303335106
Branch Code : 043826
Branch : Overport City
Reference: Surname, SA ID Number or foreign passport number
Kindly note, delegates may make reference to the following when making their reservations at Elangeni Tsogo Sun via email or call in:
• Block Name - AWACC 2019 Free Sell
• Contract Number - 1353651
Note, should the guests book online,
They will not qualify for the preferential rate offered.
This annual workshop which started in 2007 has been held yearly .The first workshop was a joint effort of the Centre for AIDS research (CFAR) of Harvard Medical school and McCord Hospital (MH) ,Durban South Africa.
Professor Bruce Walker and Dr Raj Gandhi from CFAR jointly arranged this with Dr. Henry Sunpath and Dr Helga Holst from MH. 130 delegates attended the workshop in 2007 at the Athlone Riverside hotel in Durban. The workshop received great acclaim from the delegates for its relevance to the growing ART roll out programme in South Africa (SA).
The two-day interactive workshop will translate the latest evidence-based research and apply best practice models of care into good clinical practice, specifically for resource constrained areas
- Provide updates in the management of PLHIV with opportunistic infections, ART complications and treatment failure in resource-scarce settings.
- Educate on issues related to HIV in the pediatric population, the PMTCT programme and women.
- Develop experienced clinicians to work independently and serve as consultants in HIV medicine in different district and community health institutions, and
- create an opportunity for networking between HIV clinicians, academicians, researchers and policy makers.
- Infectious Diseases Unit of the Nelson Mandela School of Medicine (NRMSM) at the University of KwaZulu-Natal (UKZN)
- The South African HIV Clinicians Society (SAHIVCS) and
- HIV-AIDS-STI-TB (HAST UNIT) OF THE KZN DEPARTMENT OF HEALTH (DOH).
All major local institutions involved in HIV care and research over the last 6 years : UKZN Health Sciences department, Centre for programme in AIDS research South Africa (CAPRISA), Hospice Palliative Care Society (HPCS-SA), University of Wits and Cape Town, Right to Care, Kwa Zulu Natal Research Institute of HIV and TB (K-RITH). Several speakers have participated from leading US universities yearly.
- Dr Henry Sunpath (MBBS; MFam Med; Dip HIVMan; MPH)
- Mr. Nash Maharaj (NDM Accounting)
- Dr. Christina Edwin (MBBS; DipHIVMan; MPhilPal Med)
The organizing committee:
- Dr Henry Sunpath (chairperson)
- Dr. Raj Gandhi (ID Unit Mass General Hospital, Harvard Medical School)
- Prof MYS Moosa (ID Unit, NRMSM at UKZN)
The conference has attracted clinicians (nurses and doctors and pharmacists) from the private sector and public sector. Each year between 300 and 400 delegates have attended. Many medical aid administrators, pharmaceutical reps, heatlh department officials and paraclinical workers have also been part of the workshop.
List of the topics covered 2007 till 2015 will reflect the many challenges unique to the times from the initial ART roll out in SA to the current programme with about 2 million PLHIV on ART. The presentations are predominantly case based discussions.
- ART guidelines: when to start
- ART toxicities: management of lactic acidosis, peripheral neuropathy and lipodystrophy
- PMTCT guidelines: sd NVP and other regimens
- Paediatric ART challenges: treating younger children
- ART related anaemia
- Management of thrombocytopenia
- Renal failure in HIV
- Approach to CNS mass lesions
- Cryptococcal meningitis
- Challenges of a limited formulary in treating HBV infection
- Management of treatment failure: use of viral load monitoring
- Second line virological failures
- Adherence measures
- Role of traditional medicines
- HIV/TB and the liver
- Persistent diarrhea
- TB AND ART guidelines
- Hepatitis B treatment guidelines
- Tenofovir and renal failure
- New SA guidelines for treatment of pt with CD4 counts<350
- Early neurogognitive disorders
- When to start ART after OI diagnosis
- Operationalisation of inpatient ART
- Surgery in HIV patients
- Dermatological manifeatations
- Kaposis Sarcoma
- Revised PMTCT guidelines
- Metabolic complications of ART
- Genotypic resistance patterns of first and second line ART in SA
- Rheumatological manifestations in HIV
- Infection control in TB
- MDR and XDR TB
- Novel /pipeline TB drugs
- Rit Lopinavir and TB treatment
- Rapid diagnostics for TB
- Linkage to care in HIV
- Quality in Chronic disease management
- Management of immunological failure
- Palliative AIDS care
- Community based care for MDR/XDR TB
- Pharmacovigilance report
- Eradication of HIV/TB
- HIV in the ageing population
- Third line salvage ART
- Transmitted resistance
- Prevention of HIV: combined startegies
- Strengthening health systems
- Starting and sequencing ART
- Retention in care
- INH preventative therapy
- Expanding ART access
- Transmitted resistance
- Drug resistance workshops
- Workshops to reduce mortality among those presenting with advanced disease
PLANS FOR 2019 ONWARDS:
1.Continued partnerships with current partners and extension of participation from other Southern African clinicians
2.Case based presentations that encourage participation and extended question and answer sessions
3.Support for DOH programme to build capacity among clinicians to manage patients who still present in advanced clinical disease. To build capacity to manage patients who fail virologically and those who may need third line ART.
4.To support systems to get PLHIV to engagae in care early and identify early warning indicators for virological failure and provide timely intervention
5.To continue to use the feedback from delegates yearly to build an academic and clinical programme of teaching